Specializing In Cardiovascular Medical Devices
CN
On July 2, 2025, KPMG, a world-renowned professional services firm, grandly held the launch ceremony of its inaugural China Healthcare Tech 50 Report and Awards Ceremony at the Global Trade Center in Beijing, honoring innovative forces in China’s ...
“The domestic substitution of imported medical devices is an irresistible trend. As a national enterprise, Pulse Medical deeply feels its arduous mission and will further accelerate breakthroughs in key core technologies to contribute to the count...
At the signing ceremony of cooperation between Guangdong Pulse and Macao Nanguang On October 10, 2024, Guangdong Pulse Medical Technology Co., Ltd. and Macau Nanguang Medical Management Consulting Co., Ltd. officially sign...
On site signing ceremony for strategic cooperation On April 18th, 2024, Guangdong Pulse Medical Technology Co., Ltd. and Johnson&Johnson Medical Technology officially signed a strategic cooperation agreement for left atria...
Good news! Guangdong Pulse Medical has won the third prize in the High Value Medical Consumables and Implant Intervention Product Category of the 6th (2023) China Medical Device Innovation and Entrepreneurship Competition! 9On Sept...
On August 12, 2023, the VB Fit Award: Top 100 Most Innovative Medical Device Products (Solutions) of 2023 was announced at the 2023 Medical Device Product Innovation and International Cooperation Summit. The Lefear® Left Hea...
On April 26th, CHC Medical Consulting and CITIC Securities officially released the "2022 China Medical and Health Industry Investment and Financing Honor List". Guangdong Pulse Medical Technology Co., Ltd. has added new reputatio...
Director Li Runqin's team from Peking University Hospital Taiyuan Hospital successfully completed the first Lefear in Shanxi Province ® Implantation of left atrial appendage occluder system On March 17, 2023, Dir...
On December 11th, the pulse medical production base was filled with festive gongs and drums, welcoming galloping lions. Relevant officials from the medical departments of Zhuhai City and High tech Zone, Academician Ge Junbo, and clinical experts g...
Guangdong Pulse Medical Technology Co., Ltd. (referred to as "Pulse Medical") has completed its Series C financing, which is jointly invested by Weilai Capital and Yuecai Biomedical Fund, with Xingyuan Zhitong serving as the exclusive financial ad...
From November 4th to November 6th, 2021, the American Conference on Transcatheter Cardiovascular Therapy (TCT 2021), which returned in a unique way, has won the attention of cardiovascular professionals worldwide. The unlocking of multiple ...
Yandao Medical Voice Network 20200708 In addition to causing symptoms such as chest tightness and palpitations, atrial fibrillation can also lead to stroke in 20-30% of patients. Compared to general stroke, the mortality and recurrenc...
On January 3, 2020, the 2020 China (Guangdong) Cardiovascular Industry Innovation and Transformation Summit Forum was held in Zhuhai. Several cardiovascular experts and hundreds of professionals from related industries at home and abroad exchanged...
The CSI Conference (Congenital and Structural Heart Disease Intervention Conference) is the top academic conference in the field of cardiovascular disease intervention therapy worldwide. The CSI Conference focuses on innovation and cutting-edge sc...
On December 8, 2018, the annual World Congress on Cardiovascular Disease was held in Dubai, United Arab Emirates. Lefear left atrial appendage occluder, a pulse medical company, has been selected as a showcase product at the World Cardiovascular D...
On December 5, 2018, the World Medical Device Innovation Conference was held in Tel Aviv, Israel. Professor Xu Yawei, Director of the Heart Center at Shanghai Tenth People's Hospital affiliated with Tongji University, and Professor Zhu Mengyu...
On November 17, 2018, the Left Heart Ear Forum of the World Structural Heart Disease Interventional Therapy Conference was held in Frankfurt, Germany, where global structural heart disease medical experts gathered. Professor Zhu Mengyun from the H...
In order to promote the innovation and development of cardiovascular technology and products in the Guangdong Hong Kong Macao Greater Bay Area, and to advance the precision of big data, personalized products, and diversified services in the cardio...
A grand cardiovascular expert seminar was held in Tel Aviv, Israel from December 4th to 6th, 2016, and ICICO (Israel China Cardiovascular Innovation Cooperation Organization) was officially established. The conference was chaired by Rafi Beyar, Ch...
# Regulations for the Supervision and Administration of Medical Devices (2021 Revision)**Order of the State Council of the People’s Republic of China No. 739**The *Regulations for the Supervision and Administration of Medical Devices*, revised and...
July 1, 2020 Fuwai Talks about Heart 2020-06-30 Author: Wen Tao On June 25th at 16:00 local time in Paris, France, at the latest clinical trial session of the European Association for Percutaneous Cardiovascular Int...
PCRe Course 2020 heavyweight moment | Professor Yawei Xu reports the latest results of registration research on the new disc left atrial appendage occluder LEFTEAR Chinese Medical Forum - Today's Circulation "by Li Shuang from the D...
The Chinese Conference on Interventional Cardiology (CIT) is the highest level academic conference on interventional treatment technology for cardiovascular disease in China and the Asia Pacific region. The annual China Interventional Cardiology C...